Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Human Genome Sciences, Inc. (HGSI) -- Ignore unavailable to you. Want to Upgrade?

To: RMP who wrote (349)	11/22/1999 5:13:00 PM
From: bucko	Read Replies (1) \| Respond to of 1127

I'M paying attention - I'm gonna retire on this one. bucko

To: RMP who wrote (349)	11/23/1999 1:16:00 AM
From: Steven Rachbach	Read Replies (1) \| Respond to of 1127

Yes, people are taking notice of HGSI and the entire sector. Today's impetus was probably concerning the deals Pfizer made with Celera and Incyte: <<New York, Nov. 22 (Bloomberg) -- Pfizer Inc., the No. 2 U.S. drugmaker, will buy genetic information from PE Corp.-Celera Genomics Group, a gene-mapping company, and collaborate on research under a five-year agreement.>> <<PALO ALTO, Calif., Nov 22 (Reuters) - Incyte Pharmaceuticals Inc <INCY.O> Monday said it expanded its collaboration with Pfizer Inc <PFE.N> in a deal that will enable it to accelerate its gene sequencing work and analyze all gene sequences as potential drug targets.>> As far as the genomics stocks being the "Internet stocks of last year", well, maybe. Neither the Internet stocks (certainly at the start of their run a few years ago) nor the genomic stocks will make big money for years. HGSI is further along than the other "clinical" genomic companies and still will have 2 or 3 years to go until their first drugs come to market. Still, the concept of genomically derived drugs is at least as compelling as the Internet-related businesses and so the HGSI share price may continue to run without any hope of earnings for years. AOL, the most mature Internet company, has a PE of 240 and a market cap of over 180 billion: HGSI's market cap of 2.5 billion is tiny in comparison. We are getting ahead of ourselves though; the ultimate result will depend on the successful development, testing and marketing of the drugs.